Literature DB >> 31216016

Coexistence of Progressive Supranuclear Palsy With Pontocerebellar Atrophy and Myotonic Dystrophy Type 1.

Shunsuke Koga1, J Eric Ahlskog2, Michael A DeTure1, Matt Baker1, Shanu F Roemer1, Takuya Konno3, Rosa Rademakers1, Owen A Ross1, Dennis W Dickson1.   

Abstract

Progressive supranuclear palsy with predominant cerebellar ataxia (PSP-C) has been reported as a rare clinical subtype, but the underlying pathology of its cerebellar ataxia remains unclear. Here, we report a patient with the coexistence of PSP with pontocerebellar atrophy and myotonic dystrophy type 1 (DM1). A 73-year-old man who was an asymptomatic carrier of DM1 (66 CTG repeats) started developing ataxic gait with multiple falls, visual blurring, double vision, and word finding difficulty at age 62 and was initially diagnosed with multiple system atrophy (MSA). Subsequently, the diagnosis was changed to PSP due to hypometric downward gaze, reduced blink frequency, symmetric bradykinesia, rigidity, and the absence of autonomic dysfunction. He eventually developed delayed grip opening with percussion myotonia at age 72. At autopsy, severe neuronal degeneration and astrogliosis in the pontocerebellar structures suggested MSA, but immunohistochemistry for α-synuclein did not reveal neuronal or glial cytoplasmic inclusions. Immunohistochemistry for phospho-tau and 4-repeat tau confirmed a neuropathological diagnosis of PSP with exceptionally numerous coiled bodies and threads in the pontine base and cerebellar white matter. This unusual distribution of 4-repeat tau pathology and neuronal degeneration with astrogliosis is a plausible clinicopathological substrate of PSP-C.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Inferior olivary hypertrophy; Myotonic dystrophy type 1; Palatal myoclonus; Palatal tremor; Pontocerebellar atrophy; Progressive supranuclear palsy; Progressive supranuclear palsy with predominant cerebellar ataxia (PSP-C)

Year:  2019        PMID: 31216016      PMCID: PMC6640894          DOI: 10.1093/jnen/nlz048

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

1.  Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy.

Authors:  A Kiuchi; N Otsuka; Y Namba; I Nakano; M Tomonaga
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 2.  Clinical and molecular aspects of the myotonic dystrophies: a review.

Authors:  Laura Machuca-Tzili; David Brook; David Hilton-Jones
Journal:  Muscle Nerve       Date:  2005-07       Impact factor: 3.217

3.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

4.  An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement.

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito; Shinsui Tatsumi; Maya Mimuro; Mari Yoshida
Journal:  Neuropathology       Date:  2013-01-16       Impact factor: 1.906

5.  Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.

Authors:  Naomi Kouri; Kenichi Oshima; Makio Takahashi; Melissa E Murray; Zeshan Ahmed; Joseph E Parisi; Shu-Hui C Yen; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2013-01-31       Impact factor: 17.088

6.  The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy.

Authors:  A Hunter; C Tsilfidis; G Mettler; P Jacob; M Mahadevan; L Surh; R Korneluk
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

7.  Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study.

Authors:  Masato Kanazawa; Takayoshi Shimohata; Yasuko Toyoshima; Mari Tada; Akiyoshi Kakita; Takashi Morita; Tetsutaro Ozawa; Hitoshi Takahashi; Masatoyo Nishizawa
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

8.  Neuropathology does not Correlate with Regional Differences in the Extent of Expansion of CTG Repeats in the Brain with Myotonic Dystrophy Type 1.

Authors:  Kyoko Itoh; Maki Mitani; Kunihiko Kawamoto; Naonobu Futamura; Itaru Funakawa; Kenji Jinnai; Shinji Fushiki
Journal:  Acta Histochem Cytochem       Date:  2010-12-18       Impact factor: 1.938

9.  The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.

Authors:  Martina Minnerop; Bernd Weber; Jan-Christoph Schoene-Bake; Sandra Roeske; Sandra Mirbach; Christian Anspach; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Thomas Klockgether; Cornelia Kornblum
Journal:  Brain       Date:  2011-11-29       Impact factor: 13.501

Review 10.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

View more
  1 in total

1.  Classification of diseases with accumulation of Tau protein.

Authors:  Gabor G Kovacs; Bernardino Ghetti; Michel Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-09       Impact factor: 6.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.